medigraphic.com

2011, Number 2

<< Back Next >>

Rev Fac Med UNAM 2011; 54 (2)

Fallopian tube occlusion and dispareunia

Sánchez-Hernández JA, Rebollo-Ramírez MF, Paulin-Badillo JA , Gómez-Linares C , Rivera-Tapia JA , Enríquez-Guerra MA

Language: Spanish
References: 25
Page: 4-9
PDF size: 175.40 Kb.


ABSTRACT

Dyspareunia (pain during or after sexual intercourse) has a multifactorial and multisystemic etiology, occurring in up to 45% of the women who have given birth. Bilateral tubal occlusion is one of the top methods in family planning in Mexico and in the world; because all surgery involves the formation of a scar and therefore pain and so the fact that Bilateral tubal occlusion can affect the terminal branches of the uterine and ovarian arteries in addition to the section of nerve fibers, it’s possible to think of general gynecological problems as side effects of this procedure. The objective of this research is to evaluate the existence of dyspareunia in women as a possible consequence of the Bilateral tubal occlusion. We analyzed the results of the questioning of all patients who attended the Laboratorio de Biología Celular to the program Early Detection of Cancer from 2001 to 2008. From a total of 921 patients, 287 were submitted to bilateral tubal occlusion, of whom 45 women (15.7%) reported dyspareunia. According to our study dyspareunia has a very low incidence in patients with bilateral tubal occlusion and therefore may not represent a side effect of this procedure.


REFERENCES

  1. Heim LJ. Evaluation and differential diagnosis of dyspareunia. Am Fam Physician. 2001;63:1535-44.

  2. Ferrero S, Ragni N, Remorgida V. Deep dyspareunia: causes, treatments, and results. Curr Opin Obstet Gynecol. 2008; 20:394-9.

  3. Latthe P, Latthe M, Say L, et al. WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity. BMC Public Health. 2006;6:177.

  4. Danielsson I, Sjöberg I, Stenlund H, et al. Prevalence and incidence of prolonged and severe dyspareunia in women: results from a population study. Scand J Public Health. 2003; 31:113-8.

  5. Valadares AL, Pinto-Neto AM, Conde DM, et al. A population- based study of dyspareunia in a cohort of middleaged Brazilian women. Menopause. 2008;15:1184-90.

  6. Wilcox LS, Martinez-Schnell B, Peterson HB, et al. Menstrual function after tubal sterilization. Am J Epidemiol. 1992; 135:1368-81.

  7. Duran B, Demirkoprulu N, Guvenal T, et al. Histopathological changes in ovary and endometrium after tubal ligation: a rat model. Acta Obstet Gynecol Scand. 2003;82: 220-4.

  8. Shobeiri MJ, Atashkhoii S. The risk of menstrual abnormalities after tubal sterilization: a case control study. BMC Womens Health. 2005;5:869-77.

  9. MacKay AP, Kieke BA Jr, Koonin LM, et al. Tubal sterilization in the United States, 1994-1996. Fam Plann Perspect. 2001;33:161-5.

  10. Boyd EM. Post-tubal-sterilization syndrome. Br J Gen Pract. 1987;37:272.

  11. Ashfaq G, Kakar F, Ahmed M. Female sterilization and its effects on women health. Pak J Med Res. 2003;42:345-51.

  12. Satoh K, Osada H. Post-tubal ligation syndrome. Ryoikibetsu Shokogun Shirizu. 1993;23:772-3.

  13. Westhoff C. Tubal sterilization--safe and effective. N Engl J Med. 2000;343:1724-6.

  14. Muldoon MJ. Gynaecological illness after sterilization. Br Med J. 1972;1:84-5.

  15. Peterson HB, Jeng G, Folger SG, et al. The risk of menstrual abnormalities after tubal sterilization. U.S. Collaborative Review of Sterilization Working Group. N Engl J Med. 2000;343:1681-7.

  16. Geber S, Caetano JP. Doppler colour flow analysis of uterine and ovarian arteries prior to and after surgery for tubal sterilization: a prospective study. Hum Reprod. Oxford, England. 1996;11:1195-8.

  17. Steege JF, Zolnoun DA. Evaluation and treatment of dyspareunia. Obstet Gynecol. 2009;113:1124-36.

  18. Stewart EG. Dyspareunia: 5 overlooked causes. OBG Management. 2003;15:50-68.

  19. Bartz D, Greenberg JA. Sterilization in the United States. Obstet Gynecol. 2008;1:23-32.

  20. Visvanathan N, Wyshak G. Tubal ligation, menstrual changes, and menopausal symptoms. J Womens Health Gend Based Med. 2000;9:521-7.

  21. De Alba QF. Quistes funcionales de ovario en pacientes con y sin esterilización tubaria. Gin Obs Mex. 2000;68:345-8.

  22. Dede FS. Color doppler flow analysis of uterine and ovarian arteries before and after tubal sterilization: electrocautery versus pomeroy. Gynecol Obstet Invest. 2006;61:45-8.

  23. Ylikorkala O. Tubal ligation reduces the risk of ovarian cancer. Acta Obstet Gynecol Scand. 2001;80:875-7.




2020     |     www.medigraphic.com